The release of DAMPs facilitates the cross-presentation of antigenic peptides on major histocompatibility complex class I (MHC I) molecules to CD8+ T cells of the adaptive immune system and generation a long-lasting immunological memory able to eliminate the tumor cells that survived during initial therapy and, therefore, achieve a complete tumor eradication [7,10,11,12]. Here, CD8A is linked to neoplasm.